Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys

Vaccine

Volumn 29, Issue 37, 2011, Pages 6269-6275

  Dong, Chenghong ^a   Liu, Longding ^a   Zhao, Hongling ^a   Wang, Jingjing ^a   Liao, Yun ^a   Zhang, Xuemei ^a   Na, Ruixiong ^a   Liang, Yan ^a   Wang, Lichun ^a   Li, Qihan ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

Enterovirus type 71; Immunogenicity; Immunoprotection; Inactivated vaccine

Indexed keywords

INACTIVATED VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENTEROVIRUS 71; ENTEROVIRUS 71 INFECTION; FEMALE; HAND FOOT AND MOUTH DISEASE; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RHESUS MONKEY; VIRUS INFECTION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; MICE; MICE, INBRED BALB C; RNA, VIRAL; VACCINES, INACTIVATED; VIRAL LOAD; VIRAL VACCINES;

EID: 80051559682     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.044     Document Type: Article

References (26)

1. Brown B.A., Pallansch M.A. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 1995, 39(December (2-3)):195-205.
2. Chan K.P., Goh K.T., Chong C.Y., Teo E.S., Lau G., Ling A.E. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 2003, 9(January (1)):78-85.
3. Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974, 129(March (3)):304-309.
4. Cardosa M.J., Perera D., Brown B.A., Cheon D., Chan H.M., Chan K.P., et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis 2003, 9(April (4)):461-468.
5. Fujimoto T., Chikahira M., Yoshida S., Ebira H., Hasegawa A., Totsuka A., et al. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol 2002, 46(9):621-627.
6. Yoke-Fun C., AbuBakar S. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol 2006, 6:74.
7. Lee M.S., Chang L.Y. Development of enterovirus 71 vaccines. Expert Rev Vaccines 2010, 9(February (2)):149-156.
8. Brown B.A., Oberste M.S., Alexander J.P., Kennett M.L., Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 1999, 73(December (12)):9969-9975.
9. Tee K.K., Lam T.T., Chan Y.F., Bible J.M., Kamarulzaman A., Tong C.Y., et al. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol 2010, 84(April (7)):3339-3350.
10. Huang S.W., Hsu Y.W., Smith D.J., Kiang D., Tsai H.P., Lin K.H., et al. Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol 2009, 47(November (11)):3653-3662.
11. Wu T.C., Wang Y.F., Lee Y.P., Wang J.R., Liu C.C., Wang S.M., et al. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol 2007, 81(October (19)):10310-10315.
12. Lin Y.W., Chang K.C., Kao C.M., Chang S.P., Tung Y.Y., Chen S.H. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J Virol 2009, 83(July (13)):6477-6483.
13. Liu M.L., Lee Y.P., Wang Y.F., Lei H.Y., Liu C.C., Wang S.M., et al. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 2005, 86(December (Pt 12)):3263-3269.
14. Chung Y.C., Ho M.S., Wu J.C., Chen W.J., Huang J.H., Chou S.T., et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26(March (15)):1855-1862.
15. Lin Y.W., Wang S.W., Tung Y.Y., Chen S.H. Enterovirus 71 infection of human dendritic cells. Exp Biol Med (Maywood) 2009, 234(October (10)):1166-1173.
16. Chua B.H., Phuektes P., Sanders S.A., Nicholls P.K., McMinn P.C. The molecular basis of mouse adaptation by human enterovirus 71. J Gen Virol 2008, 89(July (Pt 7)):1622-1632.
17. Chen Y.C., Yu C.K., Wang Y.F., Liu C.C., Su I.J., Lei H.Y. A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol 2004, 85(January (Pt 1)):69-77.
18. Wang Y.F., Chou C.T., Lei H.Y., Liu C.C., Wang S.M., Yan J.J., et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 2004, 78(August (15)):7916-7924.
19. Nagata N., Iwasaki T., Ami Y., Tano Y., Harashima A., Suzaki Y., et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol 2004, 85(October (Pt 10)):2981-2989.
20. Hagiwara A., Yoneyama T., Hashimoto I. Isolation of a temperature-sensitive strain of enterovirus 71 with reduced neurovirulence for monkeys. J Gen Virol 1983, 64(February (Pt 2)):499-502.
21. Arita M., Nagata N., Iwata N., Ami Y., Suzaki Y., Mizuta K., et al. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol 2007, 81(September (17)):9386-9395.
22. Bey E., Golombick T. A comparison of three methods for titration of poliovirus vaccines. J Virol Methods 1984 Oct, 9(October (2)):123-130.
23. Wang L.C., Tang S.Q., Li Y.M., Zhao H.L., Dong C.H., Cui P.F., et al. A Comparison of the biological characteristics of EV71 C4 subtypes from different epidemic strains. Virol Sin 2010, 25(2):98-106.
24. Liu L.D., Zhao H.L., Zhang Y., Wang J.J., Che Y.C., Li Q.H. Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. Virology 2011, 412(March (1)):91-100.
25. Ong K.C., Devi S., Cardosa M.J., Wong K.T. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 2010, 84(January (1)):661-665.
26. Arita M., Ami Y., Wakita T., Shimizu H. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol 2008, 82(February (4)):1787-1797.